BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22690721)

  • 41. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
    Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.
    Tang J; Tang Y; Yang J; Huang S
    Gynecol Oncol; 2012 May; 125(2):297-302. PubMed ID: 22307061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy.
    Schmid MP; Franckena M; Kirchheiner K; Sturdza A; Georg P; Dörr W; Pötter R
    Gynecol Oncol; 2014 May; 133(2):256-62. PubMed ID: 24517875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
    Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
    Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
    Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
    Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
    Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.
    McCann GA; Boutsicaris CE; Preston MM; Backes FJ; Eisenhauer EL; Fowler JM; Cohn DE; Copeland LJ; Salani R; O'Malley DM
    Gynecol Oncol; 2013 Apr; 129(1):135-9. PubMed ID: 23357610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures.
    Legge F; Margariti PA; Lucidi A; Macchia G; Petrillo M; Iannone V; Carone V; Morganti AG; Scambia G; Ferrandina G
    Acta Oncol; 2013 Jan; 52(1):166-73. PubMed ID: 22746313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy: a phase I study.
    Zolciak-Siwinska A; Jonska-Gmyrek J; Staniaszek J; Piotrkowicz N; Michalski W
    Int J Hyperthermia; 2012; 28(8):715-20. PubMed ID: 23126254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer.
    Gao XS; Boere IA; van Beekhuizen HJ; Franckena M; Nout R; Kruip MJHA; Kulawska MD; van Doorn HC
    Int J Hyperthermia; 2022; 39(1):1440-1448. PubMed ID: 36410740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis.
    Jung J; Park G; Kim YS
    Anticancer Res; 2014 Aug; 34(8):4361-6. PubMed ID: 25075072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.